Envista (NYSE:NVST) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS

Envista (NYSE:NVST) announced its quarterly earnings results on Thursday. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06, FiscalAI reports. Envista had a return on equity of 5.90% and a net margin of 0.58%.The company had revenue of $750.60 million during the quarter, compared to analysts’ expectations of $680.26 million. During the same period last year, the business earned $0.24 earnings per share. Envista’s quarterly revenue was up 15.0% on a year-over-year basis. Envista updated its FY 2026 guidance to 1.350-1.450 EPS.

Here are the key takeaways from Envista’s conference call:

• Strong 2025 results and cash returns: Core sales grew 6.5%, adjusted EBITDA rose ~26%, adjusted EPS was $1.19 (up $0.46), free cash flow conversion was 114%, and the company returned over $160 million via share repurchases under a $250 million program.
• 2026 guidance shows continued improvement: Management guides core growth of 2%–4%, adjusted EBITDA growth of 7%–13%, adjusted EPS of $1.35–$1.45, and ~100% free cash flow conversion, with EBITDA and EPS guidance above their medium‑term targets.
• Spark (clear aligners) is now profitable and contributing to margins and growth, with profitable quarters since Q3 and ongoing product and automation investments, though Q4 benefited partly from deferral timing that will unwind.
• Tariffs and FX remain material risks — tariffs cost the company roughly $30M in 2025 and are expected to annualize to about $40M in 2026, while prior transactional FX effects depressed margins and currency uncertainty persists.
• China VBP timing and impact are uncertain — expected ortho and implant VBPs in 2026 could cause quarter-to-quarter order volatility (company models an implant VBP likely in Q2 and ortho in H2), creating execution and timing risk given China is ~7% of sales.

Envista Stock Up 15.0%

Shares of NYSE:NVST traded up $3.70 during trading on Friday, hitting $28.41. 4,597,384 shares of the company were exchanged, compared to its average volume of 2,999,274. The firm’s 50 day moving average price is $22.63 and its 200-day moving average price is $21.16. Envista has a 12-month low of $14.22 and a 12-month high of $28.80. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02. The stock has a market capitalization of $4.67 billion, a P/E ratio of 314.93, a PEG ratio of 1.05 and a beta of 1.01.

Hedge Funds Weigh In On Envista

A number of hedge funds have recently modified their holdings of the business. Mariner LLC increased its stake in Envista by 19.7% in the third quarter. Mariner LLC now owns 13,761 shares of the company’s stock valued at $280,000 after purchasing an additional 2,264 shares during the period. Mercer Global Advisors Inc. ADV grew its holdings in shares of Envista by 101.7% during the third quarter. Mercer Global Advisors Inc. ADV now owns 20,921 shares of the company’s stock worth $426,000 after buying an additional 10,547 shares during the last quarter. Landscape Capital Management L.L.C. purchased a new position in shares of Envista during the third quarter worth about $429,000. Captrust Financial Advisors increased its position in Envista by 38.4% in the 2nd quarter. Captrust Financial Advisors now owns 15,465 shares of the company’s stock valued at $302,000 after acquiring an additional 4,290 shares during the period. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in Envista during the 2nd quarter valued at approximately $318,000.

Key Headlines Impacting Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Company press release: Envista reported Q4 2025 results showing the EPS and revenue beat and provided the new FY‑2026 EPS guidance that topped Street expectations. Envista Reports Fourth Quarter 2025 Results
• Positive Sentiment: Earnings beat summary: Analysts note Envista topped Q4 estimates on both EPS ($0.38 vs $0.32) and revenue, a core reason for the bullish reaction. Envista (NVST) Tops Q4 Earnings and Revenue Estimates
• Positive Sentiment: Market reaction coverage: Reports highlight the stock surge after the beat and the company’s “strong guidance,” reinforcing investor enthusiasm. Envista Holdings soars after beating Q4 estimates, issues strong guidance
• Neutral Sentiment: Quarter snapshot pieces summarize the beat and provide quick financials for traders and shorter‑term investors. Envista: Q4 Earnings Snapshot
• Neutral Sentiment: Deeper metric analysis: Coverage compares key Q4 metrics versus estimates and year‑ago values — useful for assessing sustainability of margin and revenue trends. Envista (NVST) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
• Neutral Sentiment: Investor resources: Conference call, slide deck and the formal press release are available for investors who want the management commentary behind the guide. View Press Release / Slide Deck
• Negative Sentiment: Valuation and profitability caveat: despite the beat, Envista’s trailing P/E is high and net margin remains thin, which could moderate upside if growth slows or guidance proves optimistic.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a report on Monday, December 29th. JPMorgan Chase & Co. lifted their price target on Envista from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Tuesday, December 16th. Piper Sandler reiterated a “neutral” rating and set a $25.00 price target (up previously from $21.00) on shares of Envista in a research report on Friday. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a report on Monday, January 26th. Finally, William Blair raised Envista from a “market perform” rating to an “outperform” rating in a research note on Friday. Seven research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $25.54.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.